T cells are a type of leukocytes that play an important role during immunologic processes. Conventional T cells require more than a week for their activation and maturation in adaptive immunity; they also contribute to chronic liver diseases, such as nonalcoholic fatty liver disease and hepatic fibrosis. (1) In contrast, innate-like T cells, such as natural killer T (NKT) cells and cd T cells, control innate responses by directly killing infected or damaged cells and regulating functions of innate cells. (2, 3) In addition, regulatory T (Treg) cells can suppress acute inflammatory responses. (4, 5) Although the role of T cells in chronic liver diseases is well studied, information on how innate T cells are activated and contribute to inflammatory responses during acute liver injury remains elusive.
Acetaminophen (APAP) is used worldwide as an analgesic and antipyretic drug. However, accidental or intentional overdoses of APAP cause acute liver damage, known as acetaminophen-induced liver injury (AILI), that is associated with high morbidity and mortality. (6) APAP is metabolized mainly by hepatic cytochrome P450 2E1 (CYP2E1) into a toxic intermediate, N-acetyl-p-benzoquinone-imine, the excessive accumulation of which rapidly causes massive hepatocyte cell death. This toxic metabolite-dependent liver injury evokes acute inflammatory responses mediated predominantly by macrophages and neutrophils. Activation of these innate immune cells further accelerates liver injury through the production of cytotoxic proteases and various cytokines, such as tumor necrosis factor a (TNF-a) and interleukin (IL)-1b. (6, 7) These excessive inflammatory responses result in severe liver necrosis and can cause lethal hepatotoxicity.
In contrast to the information available for innate immune cells, little is known on the significance and subtypes of T cells involved in the pathogenesis of AILI. Overexpression of suppressor of cytokine signaling 3 in clusters of differentiation (CD) 4 1 T cells reportedly exacerbates APAP-induced hepatotoxicity. (8) Subsequent studies suggest that Treg cells and T helper (Th)17 cells, subsets of conventional CD4 1 T cells, affect the level of APAP-elicited liver injury. Treg cells suppress liver damage presumably by regulating the activities of other effector T cells. (9) Furthermore, IL-17/IL-17A levels increase in patients with APAP-induced liver failure, (10) and a type of Th17 cells is considered to be the major source of IL-17A. (11) Among the various T-cell subtypes, NKT cells and cd T cells have been recognized as innate-like T cells and play crucial roles in AILI pathogenesis. NKT cells protect or accelerate liver damage by regulating APAP metabolism, (12, 13) whereas cd T cells are activated by macrophage-derived cytokines IL-1b and IL-23 and induce neutrophil-mediated liver injury through IL-17A production. (9) These reports indicate the pathological significance of T cells in APAP hepatotoxicity. However, the types of T cells that are involved in the pathogenesis of AILI and the way in which their activation is controlled have not been fully elucidated.
Hypoxia-inducible factors (HIFs) are key regulators of the transcriptional responses to low oxygen conditions (hypoxia) and have been reported to play crucial roles in the regulation of development, differentiation, and functions of immune cells. (14) The accumulation of immune cells and vascular injury limit oxygen availability in the inflamed tissues, resulting in HIF activation in the inflammatory cells. Beside hypoxia, inflammatory stimuli, such as lipopolysaccharide (LPS), (15) TNF-a, (16) and IL-6 (17) as well as T-cell receptor ligation (17, 18) can also activate HIF-1a transcription and translation in an oxygen-independent manner. HIF-1 negatively regulates Th1 function (19) and is required for transcriptional control of CD8 1 T-cell differentiation. (20) HIF-1 also determines the Th17/Treg balance in response to environmental cytokines. (17, (21) (22) (23) Despite these intensive studies, the way in which HIF-1 regulates the functions of T cells during acute APAP-evoked inflammation is not known. Using T-cell-specific knockout mice (KO), we found that HIF-1 inhibits excessive cd T cell infiltration into the liver and thereby limits aberrant neutrophil-mediated liver damage in APAP-induced hepatotoxicity.
Materials and Methods

MICE AND EXPERIMENTAL PROCEDURES
Mice with T-cell-specific deletion of the Hif-1a gene (THIF-1KO) were generated by breeding Hif-1a floxed mice (wild type [WT] ) (24) with Lck-cre transgenic mice that were kindly provided by Dr. Christopher Wilson (University of California San Francisco, San Francisco, CA). B6/recombination activating gene 2 (Rag2)-deficient mice were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). Mice were housed in cages containing irradiated sterile diet, autoclaved paper chips, and water under humidity-and temperature-controlled specific pathogen-free conditions in the animal facility of Tokyo Women's Medical University and Waseda University Institution. Littermate male mice aged 8-10 weeks were used for experiments. All animal experiments were carried out in compliance with the Guideline for the Care and Use of Laboratory Animals and were approved by the Committee on Animal Care and Use of Waseda University (Protocol number, 2017-A035). For detailed experimental procedures used in this study, see the Supporting Materials and Methods.
STATISTICAL ANALYSIS
Results are expressed as mean 6 SEM. Statistical analyses were performed using Mann-Whitney U tests and one-way analysis of variance followed by TukeyKramer tests for all experiments. Survival rates were compared using the log rank test. P < 0.05 was considered significant.
Results
T-CELL-SPECIFIC DELETION OF THE Hif-1a GENE EXACERBATED LIVER DAMAGE AND DECREASED SURVIVAL IN AILI
To explore the importance of HIF-1 in T cells in the pathogenesis of AILI, we administered 250 mg/kg APAP intraperitoneally to mice fasted for 24 hours. Serum alanine aminotransferase (ALT) activity peaked at 6 hours after APAP injection and gradually decreased thereafter in WT mice (Fig. 1A) . THIF-1KO mice showed levels of initial liver damage comparable to those of WT mice. However, serum ALT levels were sustained at high levels until 24 hours and were significantly higher at 24 hours and 48 hours in THIF-1KO mice than in WT mice (Fig. 1A) . Hepatic glutathione levels further decreased at 6 hours by APAP treatment but were then gradually restored in WT mice. THIF-1KO mice showed similar alterations in response to APAP, but the restoration was less in THIF-1KO mice than in WT mice (Supporting Fig. S1 ). The regression of hepatocyte necrosis (as evaluated by hematoxylin and eosin staining) was subsequently delayed in THIF-1KO mice (Fig. 1B,C) . However, the damage-induced hepatic regeneration assessed by Ki67-positive cell numbers and proliferating cell nuclear antigen (PCNA) expression occurred comparably, irrespective of Hif-1a gene status in T cells (Supporting Fig. S2A,B) . THIF-1KO mice showed greater susceptibility to APAP (250 mg/kg) with decreased survival rates compared with WT mice (Fig. 1D ). These results suggest that HIF-1 in T cells inhibits aberrant APAP-induced hepatotoxicity in the late phase of injury.
NEUTROPHIL INFILTRATION INCREASED IN THE LIVERS OF THIF-1KO MICE DURING AILI
We next investigated the type of immune cells that contribute to aggravated liver damage in THIF-1KO mice. Innate immune cells reportedly accelerate liver damage during AILI. (6) To examine the possible involvement of innate immune cells in APAP hepatotoxicity in THIF-1KO mice, isolated hepatic leukocytes were analyzed by flow cytometry. Macrophages were markedly recruited in the damaged liver 24 hours after APAP injection, but the percentage and absolute numbers of macrophages were not affected by T-cellspecific deletion of the Hif-1a gene ( Fig. 2A) . Consistent with this finding, the expressions of Tnf-a and Il-12p40, hallmarks of inflammatory M1 macrophages, also increased with APAP challenge; however, expression levels were comparable in WT and THIF-1KO mice (Fig. 2B) . Moreover, death signaling mediated by Fas ligands (FasL) reportedly induces hepatocyte death in AILI, (25) but the hepatic expressions of FasL did not differ between the two groups (Fig. 2B) . In addition, flow cytometric analysis revealed that the expressions of CD69 and FasL on NKT cells were comparable between the groups, suggesting that NKT cells are not activated by deletion of Hif-1a (data not shown). Neutrophils infiltrated substantially in the liver of APAP-treated WT mice at 12 hours, and the number remained unchanged for the next 12 hours (Fig. 2C) . In contrast, hepatic neutrophil infiltration further increased in THIF-1KO mice compared to WT mice 24 hours after APAP treatment (Fig. 2C ). This finding was further supported by immunohistochemical analysis showing that neutrophil infiltration was more evident in the necrotic regions in THIF-1KO mice than in WT mice (Fig. 2D ). Exposure to APAP has been reported to induce two major neutrophil chemoattractants, chemokine (C-X-C motif) ligand (Cxcl)1 and Cxcl2, (26) and various types of liver cells, including hepatocytes, Kupffer cells, liver sinusoidal endothelial cells, and hepatic stellate cells secrete these chemokines in LPS-induced liver inflammation. (27) Consistently, the aggravated neutrophil infiltrations were closely associated with the aberrant increase in expressions of Cxcl1 and Cxcl2 at 24 hours in APAP-treated THIF-1KO liver compared with APAP-treated WT liver (Fig. 2E ). In addition, depletion of neutrophils with anti-Gr-1 antibody markedly reduced the levels of serum ALT in APAP-treated WT mice. In contrast, the same treatment completely abolished the aggravated phenotype in THIF-1KO mice (Fig. 2F) . Collectively, these results suggest that the aggravated liver damage in THIF-1KO mice is attributable to excessive neutrophil infiltration in the late phase of AILI.
IL-17A SECRETION INDUCED NEUTROPHIL-MEDIATED LIVER INJURY IN THIF-1KO MICE
Activated T cells predominantly produce IL-17A, which induces the expressions of CXCL1 and CXCL2 and subsequently leads to neutrophil recruitment. (28, 29) Neutrophil infiltration occurred in WT mice treated with APAP (Fig. 2C ), but serum IL-17A levels did not substantially change during AILI. In contrast, the loss of the Hif-1a gene in T cells in THIF-1KO mice did not have any impacts on serum IL-17A levels for the first 12 hours after APAP injection; however, by 24 hours, serum IL-17A levels had abruptly increased (Fig. 3A) . To investigate whether increased IL-17A caused the neutrophil-mediated liver damage in THIF-1KO mice, WT and THIF-1KO mice were intravenously treated with anti-IL-17A antibody. Neutralization of IL-17A completely abolished aberrantly elevated ALT levels and also abolished the increased neutrophil accumulation in THIF-1KO mice (Fig. 3B,C) . In contrast, the treatment showed little, if any, effect on liver damage and hepatic neutrophil numbers in WT mice exposed to APAP (Fig.  3B,C) . These results suggest that HIF-1 limits excessive neutrophil infiltration and the associated liver injury by suppressing IL-17A secretion.
T-CELL-SPECIFIC
Hif-1a DEFICIENCY CONTRIBUTED TO INCREASED RECRUITMENT OF IL-17A 1 cd T
CELLS IN THE LIVER
We next investigated which types of T cells contributed to the aberrant increase in serum IL-17A in THIF-1KO mice. Isolated hepatic leukocytes were analyzed by flow cytometry after being restimulated with phorbol-12-myristial-13-acetate and ionomycin in the presence of GolgiStop. Hepatic accumulation of IL-17A 1 cd T cells but not of other T cells expressing IL-17A was significantly higher in THIF-1KO mice than in WT mice when exposed to APAP (Fig.  4A,B) . The mean fluorescence intensity of IL-17A 1 cells was notably higher in cd T cells than in other T cells but was comparable in both T-cell fractions between WT and THIF-1KO mice (Fig. 4C) . The expression of activation marker CD69 on cd T cells did not differ between the two groups (Fig. 4D) , suggesting that HIF-1 has dispensable effects on the IL-17A production of cd T cells. In contrast, cd T-cell infiltration into the damaged liver substantially increased when exposed to APAP treatment, and these responses were markedly enhanced in THIF-1KO mice compared to WT mice (Fig. 4E) . To further assess the importance of HIF-1 in cd T cells in AILI, splenic cd T cells of WT or THIF-1KO mice were adoptively transferred to Rag2-deficient mice, and mice were administrated 150 mg/kg APAP. Compared to mice receiving WT cd T cells, those receiving Hif-1a-deficient cd T cells showed elevated ALT levels and increased neutrophil accumulation in the liver (Fig. 4F) . These findings further support our hypothesis that HIF-1 prevents the accumulation of IL-17A 1 cd T cells and the aberrant increase in serum IL-17A levels exclusively by limiting the infiltration of cd T cells into the liver.
HIF-1 SUPPRESSED THE MIGRATION CAPACITY OF cd T CELLS BY INHIBITING MITOCHONDRIAL ADENOSINE TRIPHOSPHATE PRODUCTION
To examine whether the loss of the Hif-1a gene selectively promotes cd T-cell migration, Boyden chamber assays were performed using splenocytes. Because C-C chemokine ligand 20 and its chemokine receptor 6 play crucial roles in the infiltration of IL-17A 1 cd T cells into the liver, (30, 31) C-C chemokine ligand 20 was used as a chemoattractant to induce cd T-cell migration. Hif-1a-deficient cd T cells migrated to greater extents than WT cd T cells (Fig. 5A) , whereas non-cd T cells showed comparable abilities to move irrespective of Hif-1a gene status (Fig. 5B) . T cells require, in part, mitochondria-derived energy for their migration because oligomycin, an inhibitor of mitochondrial adenosine triphosphate (ATP) synthase, inhibits the migration of T cells. (32) Consistent with this report, oligomycin substantially decreased migration of either WT or THI-1KO non-cd T cells (Fig. 5B) . In contrast, the treatment slightly but not significantly reduced the migration of WT cd T cells (Fig. 5A) . On the other hand, the enhanced migration of Hif-1a-deficient cd T cells was completely abrogated to levels of WT cells by oligomycin treatment (Fig. 5A) . Furthermore, HIF-1 did not affect the total mitochondrial content of cd T cells (Fig. 5C ), suggesting that enhanced migration in Hif-1a-deficient cd T cells was not caused by increased mitochondrial biogenesis evoked by Hif-1a gene inactivation. Collectively, these results suggest that HIF-1 suppresses the migration of cd T cells, presumably by limiting mitochondrial energy metabolism.
Discussion
Tight regulation of inflammation is important to limit excessive tissue damage and to restore functional integrity rapidly after inflammation has resolved. Inflammatory responses are governed, in part, by the controlled infiltration of different types of immune cells in the affected tissue. Moreover, appropriate numbers of T cells accumulated in inflamed tissues have been implicated in the resolution of inflammation, whereas their excessive infiltration in several diseases, including drug-induced hepatitis, exacerbates inflammation. HIF-1, a key transcription factor that mediates cellular responsiveness to hypoxia, is a critical regulator of the development, differentiation, and function of various types of immune cells. However, its pathological significance in the function of T cells during acute inflammation has not been fully elucidated. Here, we showed that T-cell HIF-1 plays a critical role in regulating the infiltration of innate-like cd T cells in APAP-induced hepatitis, presumably by switching energy reliance from mitochondria to glycolysis. This switch subsequently inhibits excessive neutrophil accumulation in the damaged liver. HIF-1 in T cells prevents excessive inflammatory responses by preventing aberrant migration of cd T cells.
Accumulating evidence shows that neutrophils play an important role during AILI, although there is controversy on how infiltrated neutrophils contribute to hepatocellular damage. (33) Here, we found that THIF-1KO mice aggravated APAP hepatotoxicity with increased neutrophil infiltration into the damaged liver. These findings are consistent with those of other reports demonstrating the pathological importance of neutrophil-evoked inflammation in AILI, (7, 34, 35) and this strongly supports our hypothesis that HIF-1 in T cells inhibits excessive neutrophil accumulation and the subsequent expansion of the associated liver injury. High doses of APAP cause massive neutrophil infiltration in the necrotic region of the liver as early as 6 hours after administration. (35) The administration of neutrophil-depleting antibody or the deletion of Cxcr2, a receptor of neutrophil-chemotactic chemokines CXCL1 and CXCL2, ameliorates APAPinduced liver damage and enhances survival. (9, 34, 35) In addition, various types of liver cells, such as hepatocytes, Kupffer cells, liver sinusoidal endothelial cells, and hepatic stellate cells, secrete these chemokines to promote neutrophil infiltration in LPS-induced liver inflammation. (27) We consistently found notable increases in the hepatic expression of Cxcl1 and Cxcl2 in THIF-1KO mice, providing further evidence for crucial roles of T-cell HIF-1-regulated neutrophil recruitment in aggravated APAP hepatotoxicity. However, such inhibitory effects of HIF-1 seem to be limited to late-onset and inflammation-associated liver injury. Indeed, differences between WT and THIF-1KO mice in serum ALT levels and areas of necrosis in the affected liver became evident only after 24 hours of APAP treatment. Considering that neutrophil depletion suppresses elevation of ALT levels even in the early phase of liver insults, (35) HIF-1 in T cells displays dispensable roles in toxic metabolite-mediated early liver damage. Consistent with this hypothesis, 12 hours after APAP challenge, we observed that neutrophil accumulation occurred to similar extents irrespective of Hif-1a gene status in T cells. Although we cannot rule out the possibility that the aggravated liver injury in THIF-1KO is attributable to delayed glutathione recovery 24 hours after APAP challenge, HIF-1 in T cells indeed suppresses neutrophilmediated liver injury because neutrophil depletion completely abolished the aggravated liver injury in THIF-1KO mice. Furthermore, the aggravated hepatic injury that occurred in THIF-1KO mice could not be explained by the difference in macrophagemediated inflammatory responses because hepatic macrophage accumulation and expression of its associated proinflammatory mediators were induced to similar extents in WT and THIF-1KO mice. Collectively, this evidence suggests that HIF-1 in T cells protects against the aberrant expansion of inflammation-evoked liver damage resulting from APAP hepatotoxicity by limiting excessive neutrophil infiltration.
IL-17A, a proinflammatory cytokine primarily produced by activated T cells, stimulates neutrophil recruitment to inflamed tissues. (28, 29) Increased serum IL-17 levels have been reported in human and mouse AILI. (9) (10) (11) In contrast with the findings of these reports, we did not observe any changes in serum IL-17A levels in WT mice exposed to APAP, suggesting dispensable roles for IL-17A in our disease model. We cannot currently explain this discrepancy, although the smaller amounts of APAP used in our experiments might have failed to elicit substantial production of IL-17A. However, our hypothesis was further confirmed when we found no apparent effects of IL-17A neutralization on liver damage and neutrophil infiltration into the affected WT liver. In contrast, the aggravated APAP toxicity in THIF-1KO mice can be attributed predominantly to an aberrant increase in serum IL-17A at 24 hours after APAP challenge because anti-IL-17A neutralizing antibody completely abolished the aggravated liver damage and neutrophil recruitment in THIF-1KO mice to the levels of APAP-treated WT mice. This hypothesis is further supported by our findings showing much higher expressions of IL-17A-inducible neutrophil chemoattractants, such as Cxcl1 and Cxcl2, in THIF-1KO liver at 24 hours after APAP treatment. Although IL-17A 1 cd T cells have been reported to stimulate liver regeneration in partial hepatectomized mice, (31) IL-17A played dispensable roles in APAP-induced liver regeneration in our experiments because hepatocyte proliferation rates were not significantly different between WT and THIF-1KO mice. APAPevoked hepatic inflammation can occur in both an IL-17A-dependent and an IL-17A-independent manner, but tight regulation of local IL-17A production by HIF-1 in T cells in the immune-mediated injury phase seems to be a prerequisite for the normal inflammatory response and its resolution in the liver.
Among the various types of T cells, Th17 cells were initially recognized as the primary source of IL-17A. However, when considering the role of IL-17A in the acute inflammatory response of AILI, innate immune cells, such as NK cells, NKT cells, and cd T cells, seem to play crucial roles in the IL-17A production in AILI. Wang et al. (9) have clearly shown the importance of cd T cells as a major source of IL-17A. They also found increased accumulations of cd T cells in liver exposed to APAP. Consistent with that report, we also found a moderate but not significant increase in the number of cd T cells in APAP-challenged WT liver. Deletion of the Hif-1a gene in T cells stimulated a marked accumulation of hepatic IL-17A 1 cd T cells without any impact on their IL-17A-producing ability. Given that APAP treatment tended to reduce the numbers of hepatic NK and NKT cells irrespective of the Hif-1a gene status (Supporting Fig. S3 ) and that adoptive transfer of Hif-1a-deficient cd T cells into immunodeficient mice deteriorated AILI with enhanced neutrophil infiltrations compared to that of WT cd T cells, present findings strongly suggest that HIF-1 in T cells limits excessive infiltration of cd T cells with high IL-17A-producing ability and thus abolishes aberrant neutrophil accumulation in APAP-induced liver injury.
A coordinated regulation of immune cell migration is essential for normal inflammatory responses. (36) Our findings of a higher migratory ability of cd T cells lacking the Hif-1a gene strongly suggest that HIF-1 in T cells prevents aberrant inflammatory responses by inhibiting excessive infiltration of cd T cells into APAP-challenged liver. Furthermore, because oligomycin treatment completely abrogated the enhanced migration of Hif-1a-deficient cd T cells to the levels of WT cd T cells, this inhibitory regulation seems to occur by suppressing mitochondrial ATP generation. This finding is in sharp contrast to the stimulatory effects of HIF-1 on the migratory ability of proinflammatory macrophages and cancerous cells. (37, 38) In these cells, HIF-1 promotes cell migration exclusively by shifting cells from oxidative phosphorylation toward glycolysis to provide energy for various cell migratory processes, such as actin remodeling. Once activated, T cells also reportedly undergo a rapid metabolic reprogramming with increased glycolysis, achieved in part by activating HIF-1. (39) However, activated T cells are still likely to rely on mitochondria-associated metabolism to exert their functions. In fact, the redistribution of mitochondria and local mitochondrial ATP production occur in the uropod during T-cell migration. (32) Considering that oligomycin treatment greatly but not completely inhibits T cell chemotaxis, both mitochondriadependent and mitochondria-independent metabolic processes are prerequisites for efficient T-cell migration. This hypothesis is further supported by our observation of a partial inhibition of Hif-1a-deficient cd T-cell migration by oligomycin. Interestingly, this HIF-1-mediated regulation of T-cell migration was limited to cd T cells and was not found in other T cells in our experiments, suggesting cell-type-specific effects of HIF-1 on cell migration. Furthermore, HIF-1 reportedly inhibits mitochondrial biogenesis, (40) but the mitochondrial content of cd T cells was not affected by deletion of the Hif-1a gene in our experiments, suggesting the importance of an HIF-1-dependent reduction of metabolic fluxes into mitochondria in the regulation of cd T-cell migration. Therefore, HIF-1 appears to selectively limit excessive accumulation of cd T cells in liver exposed to APAP by suppressing their mitochondrial energy production (Fig. 6 ).
In conclusion, our study provides evidence that HIF-1 in T cells prevents aberrant APAP-induced liver injury by suppressing aberrant recruitment of proinflammatory cd T cells, thereby preventing the excessive accumulation of neutrophils. Because this newly proposed concept may extend to cd T-cellmediated acute sterile inflammation in conditions other than APAP-induced liver injury, further study is necessary to explore the scope of this new mechanism and to develop new therapies targeting HIF-1 in T cells.
